Muvalaplin
N/A
Report date: 2025/09/01 20:01:25
NME
Base Information
Drug NameMuvalaplin
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[4]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[27]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesEli Lilly And Company
China Registration ClassN/A
Develop Information
Active CompaniesEli Lilly And CompanyLilly Suzhou Pharmaceutical Co Ltd
Inactive CompaniesLilly Del Caribe Inc
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A